The positivity rates of GJB2 c.235delC, c.299_300delAT, and c.176-191del16 were 23.3, 10.3, and 4.3%, respectively, in patients with non-syndromic hearing loss in the present study cohort from Changzhou. This evidence concerns the gene GJB2 and hearing loss disorder.